MannKind Corporation (NASDAQ:MNKD) VP Diane Palumbo sold 52,957 shares of the stock on the open market in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $9.50, for a total transaction of $503,091.50. Following the completion of the sale, the vice president now directly owns 158,858 shares of the company’s stock, valued at approximately $1,509,151. MannKind Corporation (NASDAQ:MNKD) weekly performance is 29.01%. On last trading day company shares ended up $10.54. Analysts mean target price for the company is $8.58. MannKind Corporation (NASDAQ:MNKD) distance from 50-day simple moving average (SMA50) is 57.99%.
Gilead Sciences, Inc. (NASDAQ:GILD) EVP Gregg H. Alton sold 33,000 shares of Gilead Sciences stock on the open market in a transaction dated Monday, June 2nd. The stock was sold at an average price of $81.35, for a total transaction of $2,684,550.00. Following the sale, the executive vice president now directly owns 128,694 shares in the company, valued at approximately $10,469,257. Gilead Sciences, Inc. (NASDAQ:GILD) shares advanced 0.57% in last trading session and ended the day on $83.02. GILD gross Margin is 77.80% and its return on assets is 19.10%.Gilead Sciences, Inc. (NASDAQ:GILD) quarterly performance is 0.18%.
Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) EVP David Jeffrey Medeiros sold 2,292 shares of Questcor Pharmaceuticals stock on the open market in a transaction dated Monday, May 19th. The stock was sold at an average price of $89.66, for a total transaction of $205,500.72. Following the completion of the transaction, the executive vice president now directly owns 120,039 shares in the company, valued at approximately $10,762,697. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) shares moved down -1.25% in last trading session and was closed at $89.51, while trading in range of $89.39 – $91.46. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) year to date (YTD) performance is 65.91%.
InterMune Inc. (NASDAQ:ITMN) Director David S. Kabakoff unloaded 5,000 shares of InterMune stock in a transaction that occurred on Thursday, May 29th. The shares were sold at an average price of $39.56, for a total transaction of $197,800.00. Following the sale, the director now directly owns 21,600 shares in the company, valued at approximately $854,496. InterMune Inc. (NASDAQ:ITMN) ended the last trading day at $39.96. Company weekly volatility is calculated as 3.93% and price to cash ratio as 6.51.InterMune Inc. (NASDAQ:ITMN) showed a negative weekly performance of -1.04%.
Ophthotech Corp (NASDAQ:OPHT) CFO Bruce Peacock unloaded 13,931 shares of the stock on the open market in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $40.12, for a total transaction of $558,911.72. Ophthotech Corp (NASDAQ:OPHT) weekly performance is 7.06%. On last trading day company shares ended up $43.35. Analysts mean target price for the company is $63.25. Ophthotech Corp (NASDAQ:OPHT) distance from 50-day simple moving average (SMA50) is 27.65%.
Leave a Reply